Why do omega-3 fatty acids lower serum triglycerides?

Current Opinion in Lipidology

Volumn 17, Issue 4, 2006, Pages 387-393

  Harris, William S ^a,b,c   Bulchandani, Deepti ^b  

^a ST LUKE'S HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c SANFORD RESEARCH   (United States)

Author keywords

Beta oxidation; Fish oils; Lipogenesis; Rats; Triglycerides

Indexed keywords

DIACYLGLYCEROL ACYLTRANSFERASE; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PHOSPHATIDATE PHOSPHATASE; PHOSPHOLIPID; TRIACYLGLYCEROL;

BIOAVAILABILITY; BIOCHEMISTRY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ENERGY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; KINETICS; LIPOGENESIS; LIVER FUNCTION; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; NONHUMAN; PEROXISOME; PHOSPHOLIPID SYNTHESIS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION; HUMANS; RATS; TRIGLYCERIDES;

ANIMALIA;

EID: 33746040070     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000236363.63840.16     Document Type: Review

References (62)

1. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989; 30:785-807.
2. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65 (Suppl):S1645-S1654.
3. Nestel PJ, Connor WE, Reardon MR, et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984; 74:72-89.
4. Sanders TAB, Sullivan DR, Reeve J, et al. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 1985; 5:459-465.
5. Harris WS, Connor WE, Illingworth DR, et al. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 1990; 31:1549-1558.
6. Fisher WR, Zech LA, Stacpoole PW. Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet. J Lipid Res 1998; 39:388-401.
7. Bordin P, Bodamer OA, Venkatesan S, et al. Effects of fish oil supplementation on apolipoprotein B100 production and lipoprotein metabolism in normolipidaemic males. Eur J Clin Nutr JID - 8804070 1998; 52:104-109.
8. Chan DC, Watts GF, Barrett PH, et al. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem 2002; 48:877-883.
9. Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 2002; 44:455-463.
10. Park Y, Jones PG, Harris WS. Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr 2004; 80:45-50.
11. Khan S, Minihane AM, Talmud PJ, et al. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype. J Lipid Res 2002; 43:979-985.
12. Lang CA, Davis RA. Fish oil fatty acids impair VLDL assembly and/or secretion by cultured rat hepatocytes. J Lipid Res 1990; 31:2079-2086.
13. Wang H, Chen X. Fisher EA N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J Clin Invest 1993; 91:1380-1389.
14. Jump DB, Botolin D, Wang Y, et al. Fatty acid regulation of hepatic gene transcription. J Nutr 2005; 135:2503-2506. This review provides an excellent overview of the mechanisms by which n-3 FA interact with nuclear transcription factors to influence cellular metabolism.
15. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004; 41:41-78.
16. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 2004; 107:1-11.
17. Takahashi R, Okumura K, Asai T, et al. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res 2005; 68:213-223. This study highlights yet another mechanism by which n-3 FA modulate cell function. Here, increased n-3 FA in DAG alters protein kinase C migration to and assembly at the cell membrane, resulting in diminished PKC signaling, and prevention of hypertrophy.
18. Ma DW, Seo J, Switzer KC, et al. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 2004; 15:700-706.
19. Niu SL, Mitchell DC, Lim SY, et al. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to N-3 fatty acid deficiency. J Biol Chem 2004; 279:31098-31104.
20. Li Q, Wang M, Tan L, et al. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res 2005; 46:1904-1913. This study outlines a novel mechanism by which n-3 FA alter cellular function. Incorporation of DHA into the cell membrane reduces the binding of certain receptors to the membrane.
21. Aarsland A, Lundquist M, Borretsen B, et al. On the effect of peroxisomal β-oxidation and carnitine palmitoyltransferase activity by eicosapentaenoic acid in liver and heart from rats. Lipids 1990; 25:546-548.
22. Yamazaki RK, Shen T, Schade GB. A diet rich in (n-3) fatty acids increases peroxisomal β-oxidation activity and lowers plasma triacylglycerols without inhibiting glutathione-dependent detoxication activities in the rat liver. Biochim Biophys Acta 1987; 920:62-67.
23. Rustan AC, Christiansen EN, Drevon CA. Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed w-3 and w-6 fatty acids. Biochem J 1992; 283:333-339.
24. Waterman IJ, Zammit VA. Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities. Diabetes 2002; 51:1708-1713.
25. Marsh JB, Topping DL, Nestel PJ. Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the rat. Biochim Biophys Acta 1987; 922:239-243.
26. Halminski MA, Marsh JB, Harrison EH. Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis in rat liver. J Nutr 1991; 121:1554-1561.
27. Gronn M, Christensen E, Hagve TA, et al. Effects of dietary purified eicosapentaenoic acid (20:5(n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim Biophys Acta 1992; 1125:35-43.
28. Benhizia F, Hainault I, Serougne C, et al. Effects of a fish oil-lard diet on rat plasma lipoproteins, liver FAS, and lipolytic enzymes. Am J Physiol 1994; 267:E975-E982.
29. Willumsen N, Vaagenes H, Lie O, et al. Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats. Lipids 1996; 31:579-592.
30. Ikeda I, Cha JY, Yanagita T, et al. Effects of dietary alpha-linolenic, eicosapentaenoic and docosahexaenoic acids on hepatic lipogenesis and beta-oxidation in rats. Biosci Biotechnol Biochem 1998; 62:675-680.
31. Ribeiro A, Mangeney M, Cardot P, et al. Effect of dietary fish oil and corn oil on lipid metabolism and apolipoprotein gene expression by rat liver. Eur J Biochem 1991; 196:499-507.
32. Niot I, Gresti J, Boichot J, et al. Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver. Lipids 1994; 29:481-489.
33. Yeo YK, Holub BJ. Influence of dietary fish oil on the relative synthesis of triacylglycerol and phospholipids in rat liver in vivo. Lipids 1990; 25:811-814.
34. Otto DA, Baltzell JK, Wooten JT. Reduction in triacylglycerol levels by fish oil correlates with free fatty acid level in ad libitum fed rats. Lipids 1992; 27:1013-1017.
35. Ukropec J, Reseland JE, Gasperikova D, et al. The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression. Lipids 2003; 38:1023-1029.
36. Willumsen N, Skorve J, Hexeberg S, et al. The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids 1993; 28:683-690.
37. Geelen MJ, Schoots WJ, Bijleveld C, et al. Dietary medium-chain fatty acids raise and (n-3) polyunsaturated fatty acids lower hepatic triacylglycerol synthesis in rats. J Nutr 1995; 125:2449-2456.
38. Wong SH, Nestel PJ, Trimble RP, et al. The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochim Biophys Acta 1984; 792:103-109.
39. Osmundsen H, Braud H, Beauseigneur F, et al. Effects of dietary treatment of rats with eicosapentaenoic acid or docosahexaenoic acid on hepatic lipid metabolism. Biochem J 1998; 331:153-160.
40. Halvorsen B, Rustan AC, Madsen L, et al. Effects of long-chain mono-unsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats. Ann Nutr Metab 2001; 45:30-37.
41. Brown AM, Castle J, Hebbachi AM, et al. Administration of n-3 fatty acids in the diets of rats or directly to hepatocyte cultures results in different effects on hepatocellular ApoB metabolism and secretion. Arterioscler Thromb Vasc Biol 1999; 19:106-114.
42. Brown AM, Baker PW, Gibbons GF. Changes in fatty acid metabolism in rat hepatocytes in response to dietary n-3 fatty acids are associated with changes in the intracellular metabolism and secretion of apolipoprotein B-48. J Lipid Res 1997; 38:469-481.
43. Jen KLC, Alexander M, Zhong S, et al. Lipid lowering effect of omega-3 fatty acids in genetically obese Zucker rats. Nutr Res 1989; 9:1217-1228.
44. Al-Shurbaji A, Larsson-Backstrom C, Berglund L, et al. Effect of n-3 fatty acids on the key enzymes involved in cholesterol and triglyceride turnover in rat liver. Lipids 1991; 26:385-389.
45. Sebokova E, Klimes II, Knopp J, et al. Regulation of gene expression and activity of malic enzyme in liver of hereditary hypertriglyceridemic (hHTG) insulin resistant rat: effect of dietary sucrose and marine fish oil. Endocr Regul 1996; 30:5-12.
46. Neschen S, Moore I, Regittnig W, et al. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab 2002; 282:E395-E401.
47. Iritani N, Inoguchi K, Endo M, et al. Identification of shellfish fatty acids and their effects on lipogenic enzymes. Biochim Biophys Acta 1980; 618:378-382.
48. Madsen L, Rustan AC, Vaagenes H, et al. Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids 1999; 34:951-963.
49. Kanazawa A, Shirota Y, Fujimoto K. Increased hepatic beta-oxidation of docosahexaenoic acid, elongation of eicosapentaenoic acid, and acylation of lysophosphatidate in rats fed a docosahexaenoic acid-enriched diet. Lipids 1997; 32:737-744.
50. Willumsen N, Hexeberg S, Skorve J, et al. Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res 1993; 34:13-22.
51. Froyland L, Madsen L, Vaagenes H, et al. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J Lipid Res 1997; 38:1851-1858.
52. Topping DL, Trimble RP, Storer GB. Failure of insulin to stimulate lipogenesis and triacylglycerol secretion in perfused livers from rats adapted to dietary fish oil. Biochim Biophys Acta 1987; 927:423-428.
53. Otto DA, Tsai CE, Baltzell JK, et al. Apparent inhibition of hepatic triacylglycerol secretion, independent of synthesis, in high-fat fish oil-fed rats: role for insulin. Biochim Biophys Acta 1991; 1082:37-48.
54. Clarke SD, Armstrong MK, Jump DB. Dietary polyunsaturated fats uniquely suppress rat liver fatty acid synthase and S14 mRNA content. J Nutr 1990; 120:225-231.
55. Williams MA, Tinoco J, Yang YT, et al. Feeding pure docosahexaenoate or arachidonate decreases plasma triacylglycerol secretion in rats. Lipids 1989; 24:753-758.
56. Topping DL, Illman RJ, Roach PD, et al. Modulation of the hypolipidemic effect of fish oils by dietary fiber in rats: studies with rice and wheat bran. J Nutr 1990; 120:325-330.
57. Zhang ZJ, Wilcox HG, Castellani L, et al. Concentration-dependent effects of eicosapentaenoic acid on very low density lipoprotein secretion by the isolated perfused rat liver. Lipids 1993; 28:419-425.
58. Homan R, Grossman JE, Pownall HJ. Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells. J Lipid Res 1991; 32:231-241.
59. Lin Y, Smit MJ, Havinga R, et al. Differential effects of eicosapentaenoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytes. Biochim Biophys Acta 1995; 1256:88-96.
60. Lawrence JW, Li Y, Chen S, et al. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha: PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression. J Biol Chem 2001; 276:31521-31527.
61. Ren B, Thelen AP, Peters JM, et al. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J Biol Chem 1997; 272:26827-26832.
62. Raclot T, Groscolas R, Langin D, et al. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 1997; 38:1963-1972.